ABOUT US
OUR PURPOSE
Kura Biotech exists to create biotech products better and differently, to be a force of good to the world.
OUR PURPOSE
Kura Biotech exists to create biotech products better and differently, to be a force of good to the world.
OUR COMMITMENTS
We are driven by a core set of values that guide everything we do
-
Limitless SpiritWe make definitions based on potential rather than limitation. We believe in the unlimited possibilities of the human aspect, and stepping out of our comfort zones as an essential step towards evolution.
-
Human ConnectionsEmployees, partners, customers, suppliers, community. It's easy to forget that above all, they are people. We work hard not to. We understand success only as a place where business achievements meet personal blossom and pursue a human -centered organization as the core of our management style. Why? Because it's the only way.
-
Inspirational AccountabilityWe have a deep commitment to the company's success, motivating us to act in a responsible, proactive, aligned, and autonomous manner, continuously questioning our performance and that of others in pursuit of the expected outcome.That’s why we honor every one of our commitments; if we say it, we do it. We execute on the details, keeping ourselves and others accountable to the highest standards.
-
Give Back WillWe see our surroundings and community as an ally, and we commit to two socially essential challenges: Vulnerable communities and the environment. Each of our team members can contribute to their own self-realization by supporting, promoting, and actively participating in the execution of activities that move them. We don’t do charity. We give back.
-
Innovative CuriosityCuriosity is the emotional feeling that triggers exploration, which is why we push ourselves by thinking outside the box and constantly challenging and wondering what is in front of us. The perfect mix comes with action and then innovation arises.

The Beginning
Kura Biotech was founded in Puerto Varas, Chile, with the discovery of a revolutionary beta-glucuronidase (BG) enzyme for opioid detection. This enzyme would become the foundation for Finden, Kura’s flagship brand providing enzyme solutions for toxicology and drug testing.

B-Gluc World Leaders
Kura launched its highest-performance beta-glucuronidase, the fastest and most efficient enzyme in the world, which operates at room temperature and reduces hydrolysis to up to 5 minutes.

Scaling to Meet Global Needs
As the world faced the COVID-19 pandemic, Kura quickly developed and launched PCR detection kits under the Avenire brand in just 3 months. These kits were instrumental in testing millions across Chile, solidifying Kura’s role in public health and diagnostics.

Expanding into Food Safety
Building on Avenire’s success in Covid and leveraging the technology platform developed, Kura introduced RESIST Food, an Isothermal PCR for rapid pathogen detection for the food industry.

Launch of Blikka Genomics
Kura launched its genomics division, Blikka, developing cutting-edge enzymes for DNA sequencing and synthesis. Blikka’s enzymes, like the high-fidelity polymerase Decodi-Fi, are now empowering advancements in precision medicine and multi-omics research.

Commitment to Global Impact
As a certified B Corporation, Kura Biotech remains committed to sustainability and community development through the Liquen Foundation. Their innovations across Finden, Avenire, and Blikka Genomics continue to shape the industries of toxicology, food safety, and genomics.

2013
The Beginning
Kura Biotech was founded in Puerto Varas, Chile, with the discovery of a revolutionary beta-glucuronidase (BG) enzyme for opioid detection. This enzyme would become the foundation for Finden, Kura’s flagship brand providing enzyme solutions for toxicology and drug testing.

2019
B-Gluc World Leaders
Kura launched its highest-performance beta-glucuronidase, the fastest and most efficient enzyme in the world, which operates at room temperature and reduces hydrolysis to up to 5 minutes.

2020
Scaling to Meet Global Needs
As the world faced the COVID-19 pandemic, Kura quickly developed and launched PCR detection kits under the Avenire brand in just 3 months. These kits were instrumental in testing millions across Chile, solidifying Kura’s role in public health and diagnostics.

2022
Expanding into Food Safety
Building on Avenire’s success in Covid and leveraging the technology platform developed, Kura introduced RESIST Food, an Isothermal PCR for rapid pathogen detection for the food industry.

2023
Launch of Blikka for Genomics
Kura launched its genomics division, Blikka, which offers cutting-edge DNA sequencing and synthesis enzymes. This portfolio included a high-fidelity polymerase Decodi-Fi, and a proprietary TdT synthesis panel.
Blikka Genomics is now empowering advancements in precision medicine and multi-omics research.

2023
Commitment to Global Impact
As a certified B Corporation, Kura Biotech remains committed to sustainability and community development through the Liquen Foundation. Their innovations across Finden, Avenire, and Blikka Genomics continue to shape the industries of toxicology, food safety, and genomics.

Eduardo Wallach
Chief Executive Officer

Manuel Rozas
Chief Scientific Officer

Francisco Montt
Chief Financial Officer

María José Núñez
VP of Business Growth & Marketing

Shervin Kamkar
VP of Business Development, Blikka Genomics Division

Nicolás Vivanco
Chief Of Staff

Ignacia Bianchi
Director of People

Victor Flores
VP of Operations & Quality
We are moved by our Give Back Will commitment.
As a certified B Corporation, Kura Biotech holds itself to the highest standards of social and environmental responsibility. We are committed to making a lasting, positive impact on our community, business ecosystem, and the environment.
Through the Liquen Foundation, we allocate 2% of our sales to support initiatives focused on regenerating ecosystems and empowering vulnerable communities.

Our Impact Model guides every decision we make, ensuring that our actions contribute to a sustainable future.
We are moved by our Give Back Will commitment.
As a certified B Corporation, Kura Biotech holds itself to the highest standards of social and environmental responsibility. We are committed to making a lasting, positive impact on our community, business ecosystem, and the environment.
Through the Liquen Foundation, we allocate 2% of our sales to support initiatives focused on regenerating ecosystems and empowering vulnerable communities.

Our Impact Model guides every decision we make, ensuring that our actions contribute to a sustainable future.
Download Our 2023 Impact Report
Discover how Kura Biotech is making a difference in the world through our science, our people, and our commitment to sustainability.
Download Our 2023 Impact Report
Discover how Kura Biotech is making a difference in the world through our science, our people, and our commitment to sustainability.